Literature DB >> 9646860

The stereochemical mechanism of the cooperative effects in hemoglobin revisited.

M F Perutz1, A J Wilkinson, M Paoli, G G Dodson.   

Abstract

In 1970, Perutz tried to put the allosteric mechanism of hemoglobin, proposed by Monod, Wyman and Changeux in 1965, on a stereochemical basis. He interpreted their two-state model in terms of an equilibrium between two alternative structures, a tense one (T) with low oxygen affinity, constrained by salt-bridges between the C-termini of the four subunits, and a relaxed one (R) lacking these bridges. The equilibrium was thought to be governed primarily by the positions of the iron atoms relative to the porphyrin: out-of-plane in five-coordinated, high-spin deoxyhemoglobin, and in-plane in six-coordinated, low-spin oxyhemoglobin. The tension exercised by the salt-bridges in the T-structure was to be transmitted to the heme-linked histidines and to restrain the movement of the iron atoms into the porphyrin plane that is necessary for oxygen binding. At the beta-hemes, the distal valine and histidine block the oxygen-combining site in the T-structure; its tension was thought to strengthen that blockage. Finally, Perutz attributed the linearity of proton release with early oxygen uptake to the sequential rupture of salt-bridges in the T-structure and to the accompanying drop in pKa of the weak bases that form part of them. Almost every feature of this mechanism has been disputed, but evidence that has come to light more than 25 years later now shows it to have been substantially correct. That new evidence is reviewed below.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9646860     DOI: 10.1146/annurev.biophys.27.1.1

Source DB:  PubMed          Journal:  Annu Rev Biophys Biomol Struct        ISSN: 1056-8700


  138 in total

1.  Protein dynamics in an intermediate state of myoglobin: optical absorption, resonance Raman spectroscopy, and x-ray structure analysis.

Authors:  N Engler; A Ostermann; A Gassmann; D C Lamb; V E Prusakov; J Schott; R Schweitzer-Stenner; F G Parak
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

Review 2.  Structural biology.

Authors:  K C Holmes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-12-29       Impact factor: 6.237

3.  High and low oxygen affinity conformations of T state hemoglobin.

Authors:  S Bruno; M Bonaccio; S Bettati; C Rivetti; C Viappiani; S Abbruzzetti; A Mozzarelli
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

4.  Climbing mountains: a profile of Max Perutz 1914-2002: a life in science.

Authors:  Daniela Rhodes
Journal:  EMBO Rep       Date:  2002-05       Impact factor: 8.807

5.  New insights into the allosteric mechanism of human hemoglobin from molecular dynamics simulations.

Authors:  Liliane Mouawad; David Perahia; Charles H Robert; Christophe Guilbert
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

6.  Disordered allostery: lessons from glucocorticoid receptor.

Authors:  Hesam N Motlagh; Jeremy A Anderson; Jing Li; Vincent J Hilser
Journal:  Biophys Rev       Date:  2015-04-23

Review 7.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

Review 8.  The heme environment of mouse neuroglobin: histidine imidazole plane orientations obtained from solution NMR and EPR spectroscopy as compared with X-ray crystallography.

Authors:  F Ann Walker
Journal:  J Biol Inorg Chem       Date:  2006-04-04       Impact factor: 3.358

9.  Globins Scavenge Sulfur Trioxide Anion Radical.

Authors:  Paul R Gardner; Daniel P Gardner; Alexander P Gardner
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

10.  Haem conformation of amphibian nytrosylhaemoglobins detected by XANES spectroscopy.

Authors:  D Pozzi; G Amiconi; A Arcovito; M Girasole; A Congiu Castellano
Journal:  Eur Phys J E Soft Matter       Date:  2005-04       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.